Stocksigma LogoStocksigma Logo

Zydus Lifesciences Extends Timeline for 50:50 Joint Venture with Sunshine Healthcare

Zydus Lifesciences Limited and Sunshine Healthcare Lanka Limited have mutually agreed to extend the closing timeline for their proposed 50:50 joint

Zydus Lifesciences Extends Timeline for 50:50 Joint Venture with Sunshine Healthcare

Zydus Lifesciences Ltd 路 Others (Uncategorized) 路 02 Oct 2026, 3:05 am

Zydus Lifesciences Extends Timeline for 50:50 Joint Venture with Sunshine Healthcare Zydus Lifesciences Limited and Sunshine Healthcare Lanka Limited have mutually agreed to extend the closing timeline for their proposed 50:50 joint venture, Zydus Sunshine Lifesciences (Private) Limited. Following their initial agreement executed on 26th Jun'26 to acquire a 50% equity stake, both entities executed an extension letter on 1st Oct'26 as condition precedents remain ongoing. The transaction is now expected to reach final completion by Dec'26.

Original exchange filing (PDF)

More announcements from Zydus Lifesciences Ltd

All Zydus Lifesciences Ltd announcements